Human Reproduction Development & Ageing - Reproductive Endocrinology & Contraception

Topic = Reproductive Endocrinology & Contraception

Nervous and Endocrine Control System

• Humans are multicellular organisms; communication between cells occurs via the nervous system and/or endocrine system.

  • Nervous system: direct, cell-to-cell communication via nerves; fast and highly precise.

  • Endocrine system: chemical messengers (hormones) secreted into the bloodstream; slower and more variable in precision due to receptor–response dynamics.

• Endocrine glands are ductless epithelial tissues that secrete hormones into surrounding interstitial fluid and then into the bloodstream; exocrine glands secrete onto epithelial surfaces via ducts.

• Hormones are the chemical messengers of the endocrine system; categories include:

  • Steroids (lipid-soluble): e.g., Testosterone, Progesterone.

  • Peptides/Proteins (polypeptides): e.g., Oxytocin, Luteinising Hormone (LH).

  • Tyrosine derivatives (amino acid–based): e.g., Thyroxine (T4), Adrenaline.

• Hormones differ in their primary sites of action:

  • Lipid-soluble hormones diffuse across the plasma membrane and interact with intracellular receptors (cytoplasmic or nuclear), affecting gene transcription.

  • Non-lipid/peptide hormones bind cell-surface receptors and utilize second messengers inside the cell to alter metabolism.

• Important signaling concepts:

  • G protein–coupled receptors (GPCRs) transduce signals via G proteins, second messengers (e.g., cAMP, IP3, DAG, Ca^{2+}).

  • Approximately 80% of prescription drugs target GPCRs.

• Key second messengers and pathways:

  • cAMP (cyclic adenosine monophosphate)

  • cGMP (cyclic guanosine monophosphate)

  • Ca^{2+}

  • IP_3 (inositol trisphosphate) and DAG (diacylglycerol) activate downstream kinases (e.g., PKC) and Ca^{2+-dependent processes.

• Hormone action ranges from rapid signaling to long-term developmental regulation; feedback loops (positive and negative) modulate endocrine output.

Major components of the endocrine system

• Nervous system organs: brain, spinal cord, peripheral nerves, sense organs.

  • Functions: direct immediate responses, coordinate activities of organ systems, interpret sensory information.

• Endocrine system major glands: pituitary (anterior and posterior), thyroid, parathyroids, pancreas, suprarenal (adrenal) glands, gonads (testes and ovaries), and other endocrine tissues.

  • Functions: direct long-term changes in organ system activities; regulate metabolism, growth, development, and reproduction.

• Hypothalamus–pituitary axis as the master regulatory system:

  • Hypothalamus interfaces nervous and endocrine systems; releases regulatory hormones.

  • Pituitary gland (hypophysis) is the central regulator; composed of:

  • Adenohypophysis (anterior pituitary)

  • Neurohypophysis (posterior pituitary)

  • The hypothalamic–pituitary portal system delivers releasing/inhibiting hormones directly to the anterior pituitary.

  • Hormone secretion is governed by feedback loops (positive and negative).

Pituitary and hypothalamus: structure and control

• Hypothalamus releases regulatory (releasing and inhibiting) hormones that regulate the anterior pituitary.

• Anterior pituitary hormones (examples): ACTH, TSH, GH, PRL, FSH, LH, MSH.

• Posterior pituitary stores and releases: ADH (vasopressin) and OXT (oxytocin).

• The hypothalamus–pituitary axis is a hierarchical control system:

  • Direct nervous control can release hormones from the posterior pituitary.

  • Indirect control through regulatory hormones influences the anterior pituitary.

• The dual anatomical/functional structure of the pituitary:

  • Adenohypophysis (pars distalis, pars intermedia, pars tuberalis)

  • Neurohypophysis (posterior lobe)

• Embryology: pituitary development involves Rathke’s pouch (oral ectoderm) forming the anterior lobe; infundibulum from neuroectoderm forms the posterior lobe.

• Regulation of pituitary activity relies on a portal system and feedback loops, integrating neural and endocrine signals.

GnRH, gonadotrophins, and pulsatile control of reproduction

• GnRH (gonadotropin-releasing hormone) from the hypothalamus regulates the anterior pituitary secretion of LH and FSH.

• GnRH is released in pulses; frequency and amplitude encode different regulatory outcomes:

  • Pulsatile GnRH drives LH and FSH secretion in a manner that supports normal gonadal function.

  • Continuous GnRH exposure desensitizes receptors and suppresses gonadotrophin release.

• Typical pulsatile dynamics:

  • GnRH released in pulses every few hours (approx. every 1–3 hours).

  • LH surge magnitude around $6-10\times$ baseline during the follicular cycle; FSH surge around $2-3\times$ baseline.

• Gonadotrophins:

  • LH and FSH are glycoproteins composed of alpha and beta subunits; alpha subunit is common, beta subunit confers biological specificity.

  • Circulating half-life of LH and FSH is short, roughly $\sim 1\ \text{hour}$ or less.

  • LH and FSH regulate the gonads: sex hormone production and gametogenesis.

• Regulators of pituitary gonadotrophins are modulated by negative feedback from gonadal steroids (e.g., estrogen, progesterone, testosterone) and inhibins.

Male reproductive axis

• LH action on testes:

  • LH binds to receptors on interstitial (Leydig) cells -> testosterone production.

  • In fetal life, Leydig cells drive differentiation of internal male genitalia; after birth, they largely enter a quiescent state until puberty.

• FSH action on testes:

  • FSH binds to Sertoli cells -> maturation of seminiferous tubules and initiation of spermatogenesis (in the presence of testosterone).

  • Sertoli cells secrete inhibin, which provides negative feedback on the anterior pituitary.

  • Androgen-binding protein (ABP) is produced to maintain high intratesticular testosterone levels conducive to spermatogenesis.

• Negative feedback regulation:

  • Testosterone inhibits GnRH release from the hypothalamus and LH/FSH release from the pituitary.

• Summary: puberty driven by rising testosterone; in adulthood, testosterone + FSH sustains spermatogenesis and anabolic effects; LH acts via Leydig cells to maintain testosterone levels.

Female reproductive axis: ovarian and uterine cycles

• FSH drives follicular development and estrogen production by follicular cells; rising estrogen leads to endometrial proliferation.

• Estrogen and inhibin from growing follicles exert negative feedback on FSH; as the follicle matures, estrogen also exerts positive feedback on LH synthesis in the pituitary, culminating in the mid-cycle LH surge.

• LH surge (approximately $6-10\times$ baseline) triggers ovulation and formation of the corpus luteum.

• Post-ovulation, granulosa cells differentiate into luteal cells of the corpus luteum, secreting progesterone (and some estrogen) to prepare the endometrium for implantation.

• Inhibin from granulosa cells provides negative feedback on FSH; progesterone and estrogen from the corpus luteum regulate the ovarian cycle and increase basal body temperature during the luteal phase.

• Ovarian cycle phases and uterine cycle phases:

  • Follicular phase: follicle growth, rising estrogen, endometrium proliferates.

  • Ovulation: LH surge; release of oocyte.

  • Luteal phase: corpus luteum forms; progesterone dominates; endometrium becomes secretory.

  • Menstruation if no implantation (destruction of the functional zone).

• Hormonal control of the endometrium:

  • Estrogen promotes endometrial proliferation and glandular growth.

  • Progesterone promotes secretory transformation of the endometrium and supports implantation; it also modulates cervical mucus and dampens myometrial excitability.

• Key female reproductive hormones and roles:

  • Estrogens: puberty development, secondary sex characteristics, endometrial proliferation, feedback regulation of gonadotrophins.

  • Progesterone: maintains endometrium in luteal phase, prepares uterus for implantation, reduces myometrial excitability, supports mammary development.

  • Inhibin: feedback to anterior pituitary to inhibit FSH.

  • LH: stimulates ovulation and corpus luteum function; maintains corpus luteum when pregnancy occurs.

• Basal body temperature tracking reflects the hormonal shifts across the cycle.

Hormone regulation during pregnancy: placenta and fetal–placental unit

• The placenta becomes a major endocrine organ during pregnancy and, over time, takes over progesterone and estrogen production from the corpus luteum.

• Six key hormones in pregnancy (sources and primary roles):

  • Prolactin: pituitary; breast development and lactation preparation.

  • Human chorionic gonadotrophin (hCG): placenta (syncytiotrophoblast); supports corpus luteum in early pregnancy and is the hormone detected by pregnancy tests.

  • Progesterone: corpus luteum early, then placenta; maintains the uterine lining, supports placental blood vessel growth, inhibits uterine contractions, and supports late-pregnancy needs.

  • Estrogen: placenta (and corpus luteum early); supports uterine growth, keeps the uterus prepared for labor, and stimulates breast tissue development.

  • Relaxin: placenta (and ovaries during pregnancy); loosens pelvic ligaments, expands pelvic joints, relaxes cervix, and increases placental blood flow.

  • Oxytocin: posterior pituitary; promotes uterine contractions and, with prostaglandins, facilitates labor.

• The fetal–placental unit coordinates steroid hormone production; androgens from fetal adrenal glands are used by the placenta to synthesize estrogens.

• The placenta also produces human placental lactogen (hCS; also called human placental lactogen, HPL), which supports lactation and growth.

• Oxytocin receptor density in the myometrium increases during pregnancy, peaking early in labor, enabling a positive feedback loop that drives contractions when labor begins.

• Mechanisms leading to labor:

  • Estrogen increases prep for oxytocin action; oxytocin release rises and stimulates prostaglandin production; prostaglandins enhance contractions; positive feedback drives labor progression.

  • Placental hormones coordinate with maternal hormones to escalate labor readiness.

Lactation and parturition: neuroendocrine interactions

• Prolactin is the main hormone driving milk production in the mammary glands; oxytocin drives milk ejection (let-down) by contracting myoepithelial cells.

• Let-down reflex is triggered by infant suckling, which stimulates hypothalamic release of oxytocin and promotes milk ejection.

• Oxytocin receptors in the uterus and mammary glands increase during pregnancy, facilitating labor and lactation.

• Labor coordination involves estrogen priming, increased oxytocin sensitivity, and prostaglandin involvement to enhance contractions.

Contraception: principles and historical context

• Understanding reproductive endocrinology informs practical contraception strategies.

• The oral contraceptive pill (the Pill) historically used higher estrogen/progestin doses; modern formulations use lower doses to minimize adverse effects while suppressing ovulation.

• Typical pill effectiveness when used as prescribed is very high (≈ $99.75\%$).

• Progestogen-only methods (the mini-pill) have different efficacy and require strict adherence; missed doses markedly reduce effectiveness.

• Long-acting reversible contraception (LARC) includes implants and IUDs; these methods provide high efficacy with minimal daily user action.

Contraceptive methods and mechanisms

• Progestogen-only pills (mini-pills):

  • Mechanism: alters cervical mucus and may disrupt ovulation in some cycles.

  • Dosing and cycles vary; irregular patterns may occur.

  • Frequency and adherence critical since missing doses rapidly reduces effectiveness.

• Progestogen-only implants (e.g., Nexplanon/Implanon):

  • Very effective contraception (<0.1% failure in year 1).

  • Ovulation inhibition occurs quickly (often within 1 day of insertion).

  • Portable and easily removable; side effects can include irregular bleeding, headaches, nausea, mood changes.

• Progestin-releasing intrauterine devices (IUDs; Mirena):

  • Release levonorgestrel; lasts about 5 years; modifies bleeding patterns.

  • Can be used for dysmenorrhea and endometriosis beyond contraception.

• Combined oral contraceptive pills (COCs):

  • Contain estrogen and progestin; primary mechanisms include ovulation inhibition, thickening mucus, and reducing endometrial receptivity.

  • Types include fixed-dose and phasic regimens (biphasic or triphasic) with a 7-day hormone-free interval (PFI).

  • Pharmacologic effect: continuous pill-taking suppresses follicular activity; restarting pills quickly suppresses again if resumed on time; poor adherence increases risk of ovulation.

• Combined hormonal methods (patch, vaginal ring) and injectable progestin:

  • Provide systemic progestin and/or estrogen with varying dosing schedules; can achieve high efficacy but require proper use.

• Injectable contraception (e.g., Depo-Provera):

  • Progestogen injection every ~3 months; highly effective; fertility can take months to return after stopping; may cause weight gain and menstrual disturbances.

• Barrier methods and fertility-awareness strategies:

  • Barriers: condoms (male and female), diaphragms/cervical caps, spermicides.

  • Fertility awareness methods include rhythm method and lactational amenorrhea (breastfeeding) as natural family planning techniques.

• Emergency contraception options exist for specific time windows after unprotected intercourse.

Efficacy data for contraception (typical-use or perfect-use as indicated)

• Contraceptive implant: $99.95\%$ efficiency

• Vasectomy: $99.85\%$

• Hormonal IUD: $99.8\%$

• Female tubal ligation: $99.5\%$

• Contraception injection: $94\%$

• Contraceptive vaginal ring: $91\%$

• Combined oral contraceptive pill (COC): $91\%$

• Progestogen-only pill (POP): $91\%$

• Diaphragm: $88\%$

• Male condom: $82\%$

• Female condom: $79\%$

• Withdrawal: $78\%$

• Fertility awareness-based methods: $76\%$

Practical notes on contraception use and decision-making

• Effectiveness varies with perfect use vs typical use; adherence significantly impacts outcome, particularly with pills and implants.

• IUDs deliver long-term protection with high efficacy but may have side effects (e.g., bleeding changes, cramps) and require clinician insertion.

• Implants offer high efficacy and quick return to fertility after removal but can cause irregular bleeding patterns.

• Methods vary in non-contraceptive benefits (e.g., Mirena for endometriosis, dysmenorrhea management, lactation compatibility).

• Population health considerations:

  • Unplanned pregnancies still occur; contraception choice and access influence outcomes.

  • Regional differences exist in method uptake and policy coverage (e.g., Australia, US).

The Human Placenta and pregnancy hormones in detail

• Placental hormones coordinate maternal and fetal physiology to sustain pregnancy and prepare for lactation.

• hCG is produced by the placenta after implantation; it supports corpus luteum function and is a common pregnancy-test marker.

• Placental lactogen (hCS/HPL) supports lactation and growth; increases prolactin action and mammary gland development.

• Placental estrogen and progesterone production eventually dominate, supporting gestation and preparing the uterus for labor.

• Relaxin from the placenta helps remodeling of the cervix and pelvic ligaments and improves placental blood flow.

• Oxytocin from the posterior pituitary increases during labor; estrogen primes the uterus; prostaglandins increase contractions; the process involves a positive feedback loop driving labor.

Key laboratory and physiological facts worth memorizing

• GnRH is released in pulsatile fashion; frequency modulates LH/FSH release; continuous GnRH leads to desensitization.

• LH and FSH are glycoproteins with shared alpha subunits and distinct beta subunits, determining receptor binding and activity.

• The hypothalamic–pituitary portal system is the primary means by which hypothalamic hormones regulate the anterior pituitary.

• Negative feedback loops:

  • Gonadal steroids feedback to hypothalamus and pituitary to modulate GnRH, LH, and FSH levels.

  • Inhibin from gonads selectively inhibits FSH secretion.

• Positive feedback in the menstrual cycle: rising estrogen from the dominant follicle stimulates LH release, driving the mid-cycle LH surge and ovulation.

• The ovarian cycle and the uterine cycle are coordinated by hormones, with the basal body temperature rising after ovulation due to progesterone.

• The placenta transitions hormonal control during pregnancy: placenta-produced estrogen and progesterone gradually replace luteal sources; hCG supports early CL function.

Definitions and concepts (glossary-style essentials)

• Family planning: regulation of the number of children by birth control methods.

• Birth control: deliberate regulation or prevention of conception.

• Conception: fertilization; onset of pregnancy.

• Contraception: the prevention of conception by deliberate measures.

• Contraceptive (adjective): tending to prevent conception; Contraceptive (noun): a device or agent used to prevent pregnancy.

• Regulatory hormones: hypothalamic factors that regulate the anterior pituitary.

• Releasing hormones vs inhibiting hormones: stimulate or suppress hormone production in the anterior pituitary.

• Adenohypophysis vs Neurohypophysis: anterior and posterior lobes of the pituitary; different embryology and hormone profiles.

Brief historical and population context (highlights)

• Contraception history includes behavioral methods (abstinence, withdrawal, fertility awareness), barrier methods (condoms, diaphragms), and hormonal/long-acting methods.

• Global population trends show exponential growth in the 20th century with projections to 2050; contraceptive policy and access influence population dynamics.

• Contemporary debates about contraception emphasize access, safety, ethics, and the balance of efficacy with tolerability and side effects.

Quick reference figures and examples (select data points you should know)

• LH surge magnitude during the cycle: ≈ $6-10\times$ baseline.

• FSH surge magnitude during the cycle: ≈ $2-3\times$ baseline.

• GnRH pulses: approximately every $1-3\text{ hours}$.

• Half-life of LH/FSH in circulation: ≈ $1\ \text{hour}$ or less.

• Efficacy rankings (highest to lower): implant $99.95\%$, vasectomy $99.85\%$, hormonal IUD $99.8\%$, tubal ligation $99.5\%$, injection $94\%$, diaphragm $88\%$, condoms (male) $82\%$, fertility-awareness-based methods $76\%$.

• The six key pregnancy hormones and roles: hCG (placental support of corpus luteum), progesterone (placental support of pregnancy and endometrial maintenance), estrogens (uterine growth and lactation preparation), prolactin (lactation), relaxin (pelvic and connective tissue remodeling), oxytocin (labor contractions).